Abstract:
Qilong Capsules is the representative Chinese patent medicine of the theory of " invigorating Qi and activating blood circulation" in traditional Chinese medicine( TCM),with distinct characteristics of TCM in clinical application. Qilong Capsules indication on package insert is ischemic stroke( cerebral infarction),which is a complex disease and has many pathological links. The treatment principles and methods at various stages are different. Inappropriate time of intervention,dosage and course of treatment make it difficult to give full play to the efficacy,but also cause adverse reactions,such as bleeding. In order to promote the rational use of Qilong Capsules,the project team invited frontline clinical experts,pharmaceutical experts and methodologist of evidence-based medicine around China to develop the consensus. The consensus is based on a combination of clinical research evidence and expert experi-ence to give recommendations for clinical problems with evidence support and expert consensus suggestions for clinical problems without evidence support. The consensus recommends the indication,timing of intervention,dosage,course of treatment,combined medication and contraindications of Qilong Capsules in clinical application,and introduced its safety characteristics,in order to guide clinical medical workers( involving Chinese medicine,Western medicine,combining traditional Chinese and Western medicine) to use Qilong Capsules reasonably in the treatment of cerebral infarction.
摘要:
芪龙胶囊是中医益气活血理论的代表性中成药,具有鲜明的中医临床应用特色。包装说明书上的芪龙胶囊适应症为缺血性中风(脑梗塞),这是一种复杂的疾病,有许多病理联系。各个阶段的处理原则和方法不同。干预时间不当,剂量和疗程难以充分发挥疗效,还会引起不良反应,比如出血。为了促进齐龙胶囊的合理使用,项目组邀请了一线临床专家,我国各地的药学专家和循证医学方法学家形成了共识。共识基于临床研究证据和专家经验的结合,在证据支持下对临床问题提出建议,在没有证据支持的情况下对临床问题提出专家共识建议。共识建议,干预的时机,剂量,疗程,芪龙胶囊临床应用的联合用药及禁忌症,并介绍了它的安全特性,为了指导临床医务工作者(涉及中医,西医,中西医结合)合理使用芪龙胶囊治疗脑梗死。